In part one of a two-part interview, WInnovations host Dr. Kyle Richards is joined by Dr. Elizabeth Koehne, assistant professor and urologic oncologist at the University of Wisconsin Department of Urology, and Dr. Sam Chang, professor and chief of urologic oncology at Vanderbilt University, for a forward-looking discussion on emerging treatments for non-muscle invasive bladder cancer. Together, they break down key advances in care – from updates to standard surgical approaches and promising alternatives to navigating the ongoing BCG shortage and exploring new options for patients with BCG-unresponsive disease.